NCT01522833View on ClinicalTrials.gov

Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Non Small Cell Lung Cancer
Trial Locations (1)

37023

Tennessee Oncology, PLLC, Nashville

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER

NCT01522833 - Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer | Biotech Hunter | Biotech Hunter